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ABSTRACT
The aim of antimicrobial management or stewardship programmes is to ensure proper use of
antimicrobial agents in order to provide the best treatment outcomes, to lessen the risk of adverse effects
(including antimicrobial resistance), and to promote cost-effectiveness. Increasingly, long-term sustain-
ability is found to be the major focus of antimicrobial stewardship. Implementing structural measures in
healthcare institutions is therefore a major, but not the sole, focus of attention in promoting prudent use
of antibiotics. The problem of antimicrobial resistance requires common strategies at all levels—for the
prescribers and at ward, departmental, hospital, national and international levels.
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The international importance of the antibiotic
resistance issue is evident, both from recent
publications and from the number of ongoing
research projects dealing with antibiotic resistance
[1]. If the current rate of increase in resistance to
antimicrobial agents continues, it is possible that
we may see the return of the pre-antibiotic era, i.e.,
the emergence of the post-antibiotic era [2]. The
increasing emergence of clinically relevant anti-
biotic-dependent pathogens, e.g., vancomycin-
dependent enterococci, provides an impressive
illustration of this problem [3].
Although cooperative efforts among industry,
academia and government have been proposed in
order to revive the pipeline of antimicrobial
drugs, it is likely that there will be a decade or
more during which the introduction of new
antimicrobial agents will be minimal. Thus, to
ensure that options for treating infections remain,
it is imperative to make the best use of the
antimicrobial agents that are currently available.
In 1998, the WHO issued an ‘urgent’ recommen-
dation that all countries should ensure that
measures be taken to develop national guidelines
for antibiotic therapy [4]. The EC Council Recom-
mendation of 15 November 2001 concerning the
prudent use of antimicrobial agents in human
medicine considered that antimicrobial resistance
surveillance systems should be established or
strengthened, that control and preventive mea-
sures to support the prudent use of antimicrobial
agents (e.g., control systems for good practice in
marketing antimicrobial agents, and the imple-
mentation of hygiene and infection control stan-
dards in institutions) should be implemented to
limit the spread of communicable disease, that
education and training of health professionals
concerning the problem of antimicrobial resis-
tance should be promoted, and that the general
public should be informed of the importance of
prudent use of antimicrobial agents [5]. On 7
April 2005, the 58th World Health Assembly
considered that antimicrobial resistance was a
threat to global health security, and (again) called
for the rational use of antibiotics by prescribers
and patients [6]. Projects of importance funded by
DG SANCO during 2007 in relation to antimicro-
bial resistance included the European Antimicro-
bial Resistance Surveillance System (EARSS), the
European Surveillance of Antimicrobial Con-
sumption (ESAC) project, the European Commit-
tee on Antimicrobial Susceptibility Testing
(EUCAST), and the Antibiotic Stewardship Inter-
national (ABS International) project.
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The term ‘steward’ is derived from the Old
English word ‘stigweard’, combining ‘stig’ (hall)
and ‘weard’ (keeper). Therefore, stewardship
equates to ‘the managing of’. However, as Google
yields >19 million hits for ‘stewardship’, it is
apparent that the term is used widely for the
assumption of responsibility throughout the
world. Stewardship is the mantle under which
many progressive causes operate, e.g., human
rights, conservation, economic welfare, govern-
ment reform and supervision, education, health-
care, disaster relief, animal welfare, mental health
and efforts toward peace. In particular, the term
‘environmental stewardship’ is widely used as a
synonym for the responsibility of taking good care
of resources in the interest of long-term sustain-
ability. Long-term sustainability is increasingly
considered to be a major focus of antimicrobial
stewardship. MacDougall and Polk [7] deﬁne an
antimicrobial stewardship programme as an ongo-
ing effort by a healthcare institution to optimise the
use of antimicrobial agents among hospitalised
patients in order to improve patient outcomes,
ensure cost-effective therapy and reduce adverse
sequelae of antimicrobial use (including anti-
microbial resistance). Antimicrobial management
programmes have been pursuing such goals for
decades, although the term stewardship has been
applied only infrequently [7–10].
The emergence of resistant pathogens is likely
to lead to already scarce healthcare resources
being diverted to infection control efforts and
antibiotic stewardship programmes [11]. Barlam
and DiVall [12] recently investigated whether
certain antibiotic stewardship interventions are
universally instituted and accepted at top aca-
demic centres within Massachusetts, USA. There
was great variability among the approaches taken
towards overseeing antibiotic prescribing at major
academic hospitals, and antibiotic management
interventions were lacking in >50% of the Massa-
chusetts community hospitals surveyed. It was
concluded that ‘more research is needed to deﬁne
the best antibiotic stewardship interventions for
different hospital settings’ [12]. Despite many
questions remaining about the best way of ensur-
ing proper use of antimicrobial agents, providing
the best patient outcomes, reducing the risk of
adverse effects (including antimicrobial resis-
tance) and promoting cost-effectiveness, antimi-
crobial stewardship programmes can and must be
implemented now [9,13–16]. In Europe, the project
‘ABS International: implementing antibiotic strat-
egies for appropriate use of antibiotics in hospitals
in member states of the EU’ was instituted by the
EU Commission in September 2005 and will last
until September 2008. The project partners belong
to nine member states of the EU, i.e., Austria,
Belgium, the Czech Republic, Germany, Hungary,
Italy, Poland, Slovenia and Slovakia. They com-
prise universities, public health institutions, hos-
pitals and the Austrian Federal Ministry of Health,
Family and Youth. Most physicians are concerned
primarily about the effects of antimicrobial agents
on individual patients receiving care, and not
about the risk of contributing to the problem of
antimicrobial resistance in society [17]. Therefore,
mere publication of evidence-based practice
guidelines concerning the use of antimicrobial
agents is insufﬁcient to have a signiﬁcant impact
on antimicrobial prescribing patterns in a given
hospital. Furthermore, education alone, without
incorporating active intervention, is only margin-
ally effective in changing antimicrobial prescrib-
ing practices and has not yet been demonstrated to
have a sustained impact [9]. The ABS International
project aims to provide the basic tools for imple-
menting antibiotic stewardship programmes in
c. 40 European hospitals. Valid processing mea-
sures, as well as quality indicators for antibiotic
use, will be developed within the project.
None of the efforts of physicians, pharmacists,
microbiologists or infection control practitioners
to establish an antimicrobial stewardship pro-
gramme is likely to be successful without at least
passive endorsement by hospital leadership and
national health authorities [7]. The problem of
antimicrobial resistance also requires a common
strategy at the European level [18]. ABS Interna-
tional is the ﬁrst EU-funded initiative to focus on
implementing structural measures in hospitals to
promote the prudent use of antibiotics, and will
hopefully be followed by further antimicrobial
stewardship programmes.
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